ロード中...
RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision Medicine
Cetuximab and panitumumab monoclonal antibodies are a milestone in the history of treatment of metastatic colorectal cancer (mCRC) and point toward future directions for personalized treatment. Recent studies have shown that broader RAS testing is needed to select patients for targeted therapy. The...
保存先:
| 出版年: | Appl Immunohistochem Mol Morphol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6135466/ https://ncbi.nlm.nih.gov/pubmed/30199395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAI.0000000000000475 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|